MANIPULATION OF GENE EXPRESSION WITH SMALL MOLECULES
MANIPULATION OF GENE EXPRESSION WITH SMALL MOLECULES
批准号:
8147684
负责人:
Thomas J. Kodadek
金额:
$28.34万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-07-01 至 2012-05-09
关键词:
AnimalsBindingBiological AssayBiomedical ResearchCellsCellular AssayCharacteristicsChromatinCollaborationsCultured CellsDiabetes MellitusGene ChipsGene ExpressionGene TargetingGenerationsGenesGoalsHandHoloenzymesHuman Cell LineIn VitroIsocitrate DehydrogenaseLaboratoriesLeadLibrariesLifeLinkMapsMeasuresMetabolismNuclear ExtractNylonsPeptoidsPermeabilityPrincipal InvestigatorPromoter RegionsPropertyProteinsRNA Polymerase IIRecruitment ActivityReportingSpecificitySynthetic GenesTherapeutic AgentsTransactivationWorkbasechromatin immunoprecipitationcombinatorialdesigngenome-widehuman CREB1 proteinimprovedisletnovelprogramspromoterresearch studysmall moleculetooltranscription factor
中文摘要
该项目的目标是创造能够激活特定基因表达的细胞渗透性合成分子。“合成转录因子模拟物”将能够定位于特定的启动子区域,并将转录机制招募到附近的基因,从而模仿天然反式激活蛋白的基本功能。这些分子将是生物医学研究中非常有用的工具,并有可能被详细阐述为一类新的治疗剂。
可以设想,通过将DMA结合分子,特别是具有适当DMA识别特性的发夹聚酰胺与能够结合RNA聚合酶II全酶的分子融合在一起,从而将其重新招募到靶启动子上,可以创建合成激活剂。来自我们实验室和其他实验室的大量证据表明,这是一种有效的方法,但尽管有报道称合成激活剂能够在核提取液中发挥作用,但发挥作用的分子的目标是
在活细胞中的作用仍然难以捉摸。我们最近取得了一项令人兴奋的突破,发现了一种细胞通透性类肽,它在活细胞中起着相当于激活结构域的作用。这是首次观察到这种活动。我们计划将这种类肽和改进的衍生物与具有适当序列识别特性的发夹聚酰胺连接起来,以创建细胞渗透性的合成激活剂。这些化合物将被用于操纵细胞系和人类胰岛的新陈代谢。特别是,我们将
尝试激活胰岛中Nkx6.1基因和胞浆中依赖NADPH的异柠檬酸脱氢酶基因,并确定这种刺激对细胞新陈代谢的影响。这些研究将与纽加德实验室合作进行。在纽加德实验室的最新结果之后,我们还计划使用全基因组染色质免疫沉淀分析来帮助识别直接的Nkx6.1靶标
然后还将设计合成分子来启动这些基因。
在整个项目过程中,将始终如一地努力开发更有效的合成激活剂。为此,我们将利用我们开发的一种新的基于细胞的屏幕,该屏幕允许直接筛选合成组合文库的激活结构域模拟。
此外,我们还将建立细胞分析来优化聚酰胺与所需启动子的结合。
英文摘要
The goal of this project is to create cell permeable synthetic molecules capable of activating the expression of specific genes. The "synthetic transcription factor mimics" would be capable of localizing to a specific promoter region and recruiting the transcriptional machinery to a nearby gene, thus mimicking a basic function of native transactivator proteins. These molecules would be tools of outstanding utility in biomedical research and could potentially be elaborated into a new class of therapeutic agents.
It is envisioned that a synthetic activator could be created by fusing together a DMA-binding molecule, specifically a hairpin polyamide with the appropriate DMA recognition characteristics, with a molecule capable of binding the RNA polymerase II holoenzyme, thus recruiting it to the target promoter. There is considerable evidence from our laboratory and others that this is a valid approach, but while synthetic activators capable of functioning in nuclear extracts have been reported, the goal of molecules that function
in living cells remains elusive. We have recently made an exciting breakthrough with the discovery of a cell permeable peptoid that functions as an activation domain equivalent in living cells. This is the first observation of such activity. We plan to link this peptoid and improved derivatives to hairpin polyamides with appropriate sequence recognition properties to create cell permeable synthetic activators. These compounds will be employed to manipulate metabolism in cell lines and human islets. In particular, we will
attempt to activate the Nkx6.1 gene and the cytosolic, NADPH-dependent isocitrate dehydrogenase gene in islets and determine the effect of this stimulation of the metabolism of the cell. These studies will be in collaboration with the Newgard laboratory. Following the lead of recent results in the Newgard laboratory, we also plan to use genome-wide chromatin immunoprecipitation assays to help to identify direct Nkx6.1 target
genes and will also then design synthetic molecules to turn on these genes as well.
Throughout the course of this project, consistent efforts will be made to develop ever more potent synthetic activators. To do so, we will take advantage of a novel cell-based screen that we have developed which allows synthetic combinatorial libraries to be screened for activation domain mimics directly.
Furthermore, we will also set up cellular assays to optimize polyamides for binding to the desired promoters.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Establishment of a Cell-Based Screening Platform for DNA Encoded Libraries
-
批准号:10646635
-
项目类别:
-
资助金额:$33.81万
-
财政年份:2023
-
负责人:Thomas J. Kodadek
-
依托单位:
Molecular Cloaking Devices for Manipulation of Cysteine Post-Translational Modifications
-
批准号:10507541
-
项目类别:
-
资助金额:$49.68万
-
财政年份:2022
-
负责人:Thomas J. Kodadek
-
依托单位:
Phenotypic screening using DNA-encoded libraries
-
批准号:10238888
-
项目类别:
-
资助金额:$59.51万
-
财政年份:2018
-
负责人:Thomas J. Kodadek
-
依托单位:
Phenotypic screening using DNA-encoded libraries
-
批准号:10622655
-
项目类别:
-
资助金额:$18.12万
-
财政年份:2018
-
负责人:Thomas J. Kodadek
-
依托单位:
Phenotypic screening using DNA-encoded libraries
-
批准号:10001013
-
项目类别:
-
资助金额:$77.15万
-
财政年份:2018
-
负责人:Thomas J. Kodadek
-
依托单位:
Discovery of Potent Proteasome Agonists to Improve Proteostasis
-
批准号:9388111
-
项目类别:
-
资助金额:$33.34万
-
财政年份:2017
-
负责人:Thomas J. Kodadek
-
依托单位:
Discovery of antibody biomarkers for Alzheimer’s Disease
-
批准号:9092101
-
项目类别:
-
资助金额:$33.6万
-
财政年份:2016
-
负责人:Thomas J. Kodadek
-
依托单位:
Discovery of antibody biomarkers for Alzheimer’s Disease
-
批准号:9265411
-
项目类别:
-
资助金额:$19.2万
-
财政年份:2016
-
负责人:Thomas J. Kodadek
-
依托单位:
HTS for Direct Targeting of the Transcription Factor MITF
-
批准号:9109569
-
项目类别:
-
资助金额:$53.42万
-
财政年份:2014
-
负责人:Thomas J. Kodadek
-
依托单位:
Discovery and Treatment of the Early Autoimmune Reaction In Type 1 Diabetes
-
批准号:8240614
-
项目类别:
-
资助金额:$502.92万
-
财政年份:2011
-
负责人:Thomas J. Kodadek
-
依托单位:
Chemical Inhibitors of the Proteasomal ATPases
-
批准号:7905124
-
项目类别:
-
资助金额:$38.14万
-
财政年份:2009
-
负责人:Thomas J. Kodadek
-
依托单位:
NOVEL MOLECULAR IMAGING AGENTS
-
批准号:7956957
-
项目类别:
-
资助金额:$1.78万
-
财政年份:2009
-
负责人:Thomas J. Kodadek
-
依托单位:
NEW CHEMISTRY FOR MULTIPROTEIN COMPLEXES
-
批准号:7724107
-
项目类别:
-
资助金额:$1.05万
-
财政年份:2008
-
负责人:Thomas J. Kodadek
-
依托单位:
NEW CHEMISTRY FOR MULTIPROTEIN COMPLEXES
-
批准号:7600841
-
项目类别:
-
资助金额:$1.51万
-
财政年份:2007
-
负责人:Thomas J. Kodadek
-
依托单位:
Project 3: MANIPULATION OF GENE EXPRESSION WITH SMALL MOLECULES
-
批准号:7556983
-
项目类别:
-
资助金额:$35.18万
-
财政年份:2007
-
负责人:Thomas J. Kodadek
-
依托单位:
Novel Chemistry to Monitor and Manipulate the Immune System
-
批准号:7191786
-
项目类别:
-
资助金额:$78.5万
-
财政年份:2006
-
负责人:Thomas J. Kodadek
-
依托单位:
MANIPULATION OF GENE EXPRESSION WITH SMALL MOLECULES
-
批准号:7141450
-
项目类别:
-
资助金额:$32.79万
-
财政年份:2006
-
负责人:Thomas J. Kodadek
-
依托单位:
Novel Chemistry to Monitor and Manipulate the Immune System
-
批准号:7292772
-
项目类别:
-
资助金额:$78.5万
-
财政年份:2006
-
负责人:Thomas J. Kodadek
-
依托单位:
Novel Chemistry to Monitor and Manipulate the Immune System
-
批准号:7919258
-
项目类别:
-
资助金额:$97.25万
-
财政年份:2006
-
负责人:Thomas J. Kodadek
-
依托单位:
NEW CHEMISTRY FOR MULTIPROTEIN COMPLEXES
-
批准号:7180723
-
项目类别:
-
资助金额:$1.05万
-
财政年份:2005
-
负责人:Thomas J. Kodadek
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: